INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 1991

Weight reduction did not produce clinically meaningful shifts in serum lipoprotein(a) concentrations.

Fifty-two moderately obese white adults participated in a 104-week placebo-controlled, double-blind weight reduction intervention combining lifestyle modifications with fenfluramine and phentermine. Baseline serum lipoprotein(a) displayed a skewed distribution comparable to that reported in healthy adults. Despite successful weight loss that normalized fasting insulin and standard lipid levels, no clinically significant modification in serum lipoprotein(a) occurred.

Study type
Double-blind, placebo-controlled trial
Who was studied
52 moderately obese white adults (16 men, 36 women)
What was measured
Serum lipoprotein(a) and lipid profiles

THE PAPER

Effect of weight loss on serum lipoprotein(a) concentrations in an obese population.

Corsetti JP, Sterry JA, Sparks JD, Sparks CE, Weintraub M. Clin Chem, 1991.

PubMed 1830250 ↗

Heart & arteriesWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.